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Sterols are a major component of eukaryotic cell membranes. For human fungal
infections caused by the filamentous fungus Aspergillus fumigatus, antifungal drugs
that target sterol biosynthesis and/or function remain the standard of care. Yet, an
understanding of A. fumigatus sterol biosynthesis regulatory mechanisms remains an
under developed therapeutic target. The critical role of sterol biosynthesis regulation and
its interactions with clinically relevant azole drugs is highlighted by the basic helix loop
helix (bHLH) class of transcription factors known as Sterol Regulatory Element Binding
Proteins (SREBPs). SREBPs regulate transcription of key ergosterol biosynthesis genes
in fungi including A. fumigatus. In addition, other emerging regulatory pathways and
target genes involved in sterol biosynthesis and drug interactions provide additional
opportunities including the unfolded protein response, iron responsive transcriptional
networks, and chaperone proteins such as Hsp90. Thus, targeting molecular pathways
critical for sterol biosynthesis regulation presents an opportunity to improve therapeutic
options for the collection of diseases termed aspergillosis. This mini-review summarizes
our current understanding of sterol biosynthesis regulation with a focus on mechanisms
of transcriptional regulation by the SREBP family of transcription factors.
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INTRODUCTION
Aspergillus fumigatus is an environmental filamentous fungus and is the major causal agent of the
collection of diseases known as aspergillosis (Kwon-Chung and Sugui, 2013). With increase use of
immune suppressive therapies to treat many human diseases, the incidence of invasive aspergillosis
(IA) is on the rise with mortality rates between 30–95% (reviewed in Brown et al., 2012). Though
comprehensive epidemiology studies are currently lacking for aspergillosis, a recent estimate
suggests more than 3 million people have invasive or chronic A. fumigatus infection potentially
leading to more than 600,000 deaths a year (Gsaller et al., 2016). The major drugs used to treat
aspergillosis target ergosterol, the fungal cholesterol equivalent, and belong to the polyene and azole
classes of antifungal drugs. Amphotericin B is the major polyene used in the context of IA, however,
due to host toxicity concerns it is now primarily used for salvage therapy (reviewed in Gallis et al.,
1990; Patterson et al., 2016). The azole class of drugs that target the cytochrome P-450 enzyme
eburicol 14α-demethylase (encoded by the cyp51A/B/erg11A/B genes) in the ergosterol pathway
are the major class of drugs used to treat IA (Patterson et al., 2016). Anti-fungal properties of azoles
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have been long documented, however, agricultural use of azoles as
a fungicide is proposed to lead to azole resistance in A. fumigatus
(Snelders et al., 2009; Chowdhary et al., 2013). Environmental
azole resistant isolates have emerged in clinics throughout the
world and are associated with high mortality rates (reviewed
in Verweij et al., 2016). Affinity binding analysis reveals azoles
directly bind with high affinity to Cyp51 class of proteins in
various organisms including A. fumigatus (Podust et al., 2001;
Warrilow et al., 2010, 2013). In A. fumigatus, azoles bind to
both Cyp51A and Cyp51B, albeit azole binding is tighter to
Cyp51B (Warrilow et al., 2010). It is worth noting that azoles
are effective in controlling growth of Aspergillus, but they are
mostly fungistatic against the majority of A. fumigatus isolates
(Meletiadis et al., 2007). Thus, a better understanding of the
molecular mechanisms associated with sterol biosynthesis is
needed to develop new therapeutic strategies particularly in the
face of emerging triazole resistance.
STEROL BIOSYNTHESIS IN Aspergillus
fumigatus
Sterols are isoprenoid derived molecules and are a major
component of eukaryotic cell membranes; necessary for fluidity,
permeability and protein function. Fungi are among the oldest
eukaryotes known to synthesize sterols (reviewed in Parks and
Casey, 1995). Unlike mammals that have cholesterol as the
preferred membrane sterol, fungi synthesize ergosterol. The
synthesis of ergosterol begins with acetyl-coA and involves 20
steps (Figure 1) (da Silva Ferreira et al., 2005; Alcazar-Fuoli
et al., 2008). This process is metabolically costly requiring large
amounts of ATP equivalents, reducing power in the form of
NADPH, heme-iron, and 12 oxygen molecules (Chang et al.,
2007; reviewed in Parks and Casey, 1995; Rosenfeld and Beauvoit,
2003). As molecular oxygen is necessary for sterol production
and sterols are only found in eukaryotes, Galea and Brown
hypothesize a direct correlation between eukaryotic aerobic life-
style and sterols (Galea and Brown, 2009).
Thus, it is plausible that selective pressure exerted by oxygen
on primitive life forms led to the emergence of sterols. Oxidative
metabolism via mitochondria leads to production of reactive
oxygen species (ROS) and eukaryotic organisms have developed
strategies to counter intrinsic ROS production (reviewed in
Apel and Hirt, 2004; Lambou et al., 2010). Understanding these
mechanisms has implications for understanding current sterol
targeting antifungal drug mechanisms and in developing new
therapeutic approaches. In support of this hypothesis, azole
resistant isolates of C. glabrata have lower ATP production and
lower intrinsic ROS production, possibly due to impairment
of mitochondrial function (Peng et al., 2012). In other clinical
strains of C. albicans and C. glabrata, azole resistance shows
a strong negative correlation with ROS production (Kobayashi
et al., 2002). Thus, oxygen plays an important role in azole
mediated sensitivity in various fungi and ROS production plays
an integral and yet to be fully defined role in azole drug
function. Importantly, given the proposed mechanism of action
of the azole class of antifungal drugs on A. fumigatus, more
research is needed to understand the mechanisms linking sterol
biosynthesis, oxygen levels, and fungal fitness during azole
therapy.
Along these lines, these observations suggest a role for sterols
in preventing oxidative damage by molecular oxygen. In support
of a sterol mediated oxidative damage prevention mechanism,
exposure of red blood cells (RBCs) to hyperbaric oxygen
(HBO), which is associated with oxidative damage, increases
RBC’s cholesterol levels (Miliutina et al., 1992). However,
the RBC’s oxygen carrying capacity is inversely correlated
with cellular cholesterol content (Buchwald et al., 2000). One
possible explanation for these observations is that HBO increases
oxygen solubility in plasma reducing the load on RBCs to
meet cellular oxygen demand. Moreover, 3β-Hydroxysterol-124-
reductase (DHCR24), the enzyme that catalyzes the penultimate
step in cholesterol biosynthesis, scavenges ROS providing a
potential causal link between increased cholesterol levels under
prolonged oxygen exposure (Lu et al., 2008). Finally, cats exposed
to HBO show a 150% increase in intra-alveolar cholesterol
levels (Bergren and Beckman, 1975). However, the relationship
between increased sterol levels, ROS resistance, and antifungal
drug efficacy remains enigmatic. Some answers may be found
in understanding the function and regulation of key sterol
biosynthesis enzymes.
Synthesis of HMG-CoA is the first committed step in
the biosynthesis of isoprenoids. HMG-CoA reductase catalyzes
HMG-CoA to mevalonate and is the rate-limiting in eukaryote
sterol biosynthesis (Figure 1) (Brown et al., 1973). Two major
pathways of ergosterol biosynthesis are proposed after the
formation of the first sterol, lanosterol. Lanosterol can be
converted to zymosterol or eburicol and this appears to be
fungal species dependent. In the model yeast Saccharomyces
cerevisiae where sterol biosynthesis in fungi is extensively studied,
conversion to zymosterol is favored, while eburicol formation is
the preferred choice in the human pathogen A. fumigatus under
conditions examined to date (Fryberg et al., 1973; Nes et al.,
1989; Alcazar-Fuoli et al., 2008). Both pathways converge at the
formation of fecosterol (Alcazar-Fuoli et al., 2008). Fecosterol
conversion to episterol is a unique reversible reaction in the
ergosterol pathway; however, evidence suggests that episterol
production is favored (Nes et al., 2002). This may explain why
fecosterol is not detected in A. fumigatus (Alcazar-Fuoli et al.,
2008). Three synthetic pathways have been proposed for the
conversion of episterol to ergosterol in fungi (reviewed in Nes
et al., 1989; Benveniste, 2004). In A. fumigatus, intermediates for
two pathways have been identified, which suggests at least two of
the possible three pathways are functional. Figure 1 summarizes
genes known or predicted to encode enzymes or regulators of
the ergosterol biosynthesis pathway in A. fumigatus. Importantly,
many of these genes remain to be functionally characterized in
this important human pathogen.
One potential reason for the lack of genetic analyses on
sterol biosynthesis and function in A. fumigatus is that many
steps in the biosynthetic pathway involve multiple copies of
genes encoding the respective enzymes. For example, two 14-
α eburicol demethylases (Cyp51A and Cyp51B) (Mellado et al.,
2001) and three C5 desaturases (Erg3a, 3b, and 3c) are present
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FIGURE 1 | The canonical fungal ergosterol biosynthetic pathway.
Biosynthesis of ergosterol from Acetyl-coA depicting intermediate steps and
enzymes catalyzing the intermediate reactions. Known regulators of Erg genes
are shown on right side, whereas anti-fungal agents targeting various pathway
steps are shown on the left of the pathway. ∗Signifies the pathway differences
in Aspergillus fumigatus and Saccharomyces cerevisiae. In S. cerevisiae,
Cyp51 converts lanosterol into C4 methylated sterols which are demethylated
by Erg24 and Erg25 into zymosterol. Erg6 then converts zymosterol into
fecosterol.
in A. fumigatus (Alcazar-Fuoli et al., 2006). Mutants lacking
cyp51A in the ergosterol biosynthetic pathway can grow in vitro
and are virulent in an IPA murine model (Mellado et al.,
2005). This is in contrast with S. cerevisiae strains that lack a
single erg11 gene (cyp51A in A. fumigatus) and cannot grow
aerobically (Bard et al., 1993). However, generation of a double
gene replacement mutant (cyp51A and cyp51B) in A. fumigatus is
lethal under standard laboratory conditions. Moreover, a strain
with cyp51A expression under control of a nitrogen source
conditional promoter (niiA) and a genetic null mutation of
cyp51B (niiA(p)::cyp51A,1cyp51B) is unable to establish murine
infection (Hu et al., 2007). The sterol profile of the cyp51a
null mutant is similar to WT, however, a complete lack of
Cyp51 activity leads to accumulation of 14-α methylated sterols,
similar to treatment with triazole antifungal drugs that target
this important step in sterol biosynthesis. It is important to
note that indigenous host sterol was not able to complement
the sterol phenotype of the niiA(p)::cyp51A, 1cyp51B double
mutant in the IPA murine model (Hu et al., 2007). Thus, it is
clear that sterol levels are important for growth and survival of A.
fumigatus making sterol biology an attractive target for control of
aspergillosis.
STEROL TARGETING DRUGS USED TO
COMBAT ASPERGILLOSIS
The fungal membrane maintains cellular homeostasis in part
through optimization of phospholipid, sphingolipid and sterol
levels. As mentioned, antifungal drugs in the polyene and
azole class target cell membrane homeostasis through their
effects on sterols. Amphotericin B, a polyene class of anti-
fungal drug irreversibly binds to ergosterol and this binding is
paramount to fungal killing. Binding of Amphotericin B to sterols
in membranes causes membrane leakage and is the proposed
mechanism leading to cell death (Gray et al., 2012). A main
advantage of Amphotericin B as an anti-A. fumigatus drug is its
recalcitrance to resistance emergence perhaps due in part to its
cidal activity (Meletiadis et al., 2007; Gray et al., 2012). However,
its dose dependent toxicity to host cells is a major and significant
limitation. Consequently, triazoles (primarily voriconazole and
posaconazole) have become the primary choice of treatment for
IA (Patterson et al., 2016).
Voriconazole targets heme containing P450 monooxygenase
proteins, Cyp51A and Cyp51B, which catalyzes P450 dependent
demethylation at C-14 position (reviewed in Ghannoum
and Rice, 1999; Mast et al., 2010; Warrilow et al., 2010).
Cell membrane integrity requires that embedded sterols
lack C-4 methyl groups (Nes et al., 1993). Treatment with
voriconazole leads to depletion of ergosterol and accumulation
of lanosterol and toxic 14-α-methylated sterols in the plasma
membrane. In voriconazole treated C. albicans, accumulation
of squalene, zymosterol, 4,14-Dimethylzymosterol, 24-
methylenedihydrolanosterol and lanosterol is observed (Sanati
et al., 1997). In contrast, eburicol and 4α-methyl sterol
accumulation is observed in voriconazole treated A. fumigatus
(Xiong et al., 2005). It is not clear if voriconazole targets
additional enzymes in the ergosterol biosynthetic pathway or
if these intermediate accumulations are due to indirect effects
of accumulating methylated sterols. Voriconazole is effective
against itraconazole resistant A. fumigatus isolates (Abraham
et al., 1999; Dannaoui et al., 2006). It is interesting to note
that both azoles target Cyp51 proteins, thus the mechanisms
conferring lack of cross resistance needs further investigation
(reviewed in Mayr and Lass-Flörl, 2011; reviewed in Odds et al.,
2003). Consequently, the azole and polyene drug classes further
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demonstrate the critical importance for sterol homeostasis in
A. fumigatus and other fungi.
REGULATION OF STEROL
BIOSYNTHESIS IN A. fumigatus
Sterol Regulatory Element Binding
Proteins (SREBP) Transcriptional
Regulation
Given the evolutionary conservation of sterol biosynthesis in
eukaryotes, much can be learned about sterol biosynthesis
mechanisms in A. fumigatus through examination of more
well studied systems in yeast and mammals among others.
While many mechanisms are conserved, it is clear that each
organism has evolved unique regulatory mechanisms and
this is particularly true for A. fumigatus as discussed below.
Importantly, these unique mechanisms present opportunities
to develop novel therapeutic strategies to augment existing
antifungal drugs or identify new targets and molecules with
activity against A. fumigatus.
De novo synthesis and LDL receptor mediated endocytosis
are two major pathways through which mammalian cells fulfill
their sterol requirement (Brown and Goldstein, 1986; reviewed
in Espenshade and Hughes, 2007). In mammals, levels of
cholesterol are known to control both of these pathways at
the transcriptional level (Brown and Goldstein, 1997). The
Sterol Regulatory Element Binding Protein (SREBP) class of
transcription factors (TF) bind SRE elements and function as
major regulators of sterol levels in mammalian cells (Yokoyama
et al., 1993; Brown and Goldstein, 1997). When cells are depleted
of sterol, the transcription of HMG-CoA reductase and LDL
receptor increase through SREBP binding of sterol regulatory
element (SRE) DNA elements in promoter regions of these genes.
Three major SREBP’s have been identified in mammalian cells
viz., SREBP-1a and SREBP-1c encoded by the same gene, and
SREBP-2 (Yokoyama et al., 1993; Hua et al., 1995).
Sterol Regulatory Element Binding Proteins are bHLH TFs
synthesized as ER resident proteins with their N and C terminals
in the cytosol. The SREBP binding partner, SCAP (Sterol
Cleavage Activating Protein), regulates the activation of SREBPs
(Rawson et al., 1999). When cellular sterol levels are replete,
SCAP binds sterols and consequently promotes binding to INSIG
(another ER resident protein) to prevent ER exit of SREBP-SCAP.
When cellular sterol levels are reduced, SCAP does not bind
INSIG which allows ER exit of SREBP via COPII vesicles (Brown
et al., 2002; Yang et al., 2002; Sun et al., 2005). In the Golgi,
SREBPs are sequentially proteolytically cleaved by golgi resident
site-1 serine protease (S1P) that cuts SREBP in the luminal loop
(Duncan et al., 1997) and site-2 zinc metallo protease, (S2P)
that cuts in the transmembrane domain (Rawson et al., 1997;
Duncan et al., 1998). These proteolytic cleavage events release
the N terminal TF for nuclear localization and activation of gene
expression (Espenshade, 2006; Espenshade and Hughes, 2007).
In the fission yeast Schizosaccharomyces pombe, seminal
studies identified and characterized fungal homologs of SREBP
(Sre1), Scap (Scp1), and Insig (Ins1) (Hughes et al., 2005).
As in mammalian cells, Sre1 physically interacts with Scp1
and Sre1 activity is essential to maintain cellular sterol levels
through transcriptional regulation of target genes including
oxygen dependent steps in the ergosterol biosynthesis pathway
(e.g., erg11, erg25, erg3, erg5, erg6) (Hughes et al., 2005, 2007a;
Todd et al., 2006). A major activation signal for S. pombe Sre1
proteolytic cleavage is hypoxia. Under low oxygen concentrations
that induce hypoxia in fission yeast, ergosterol levels are reduced
and this in turn induces proteolytic cleavage of Sre1. Thus,
in fission yeast ergosterol levels act as an indirect oxygen
sensor (Hughes et al., 2005). These data further highlight the
mechanistic relationship between sterol biosynthesis and oxygen
discussed previously. Cleavage of Sre1 is also stimulated by drugs
that inhibit ergosterol biosynthesis including the azoles (Hughes
et al., 2005, 2007a). Consequently, in fission yeast, ergosterol
regulates Sre1-Scp1 ER-Golgi transport, cleavage and activation
(Porter et al., 2010). Like mammalian cells, direct binding of
ergosterol to Sre1-Scp1 complex determines the fate of Sre1
cleavage, however, unlike mammalian cells, this is independent
of Ins1 binding (Porter et al., 2010). In S. pombe, the INSIG
homolog Ins1 does not regulate the SREBP pathway. Rather, Ins1
regulates HMG-CoA-reductase (hmg1) that catalyzes HMG-CoA
to mevalonate; the first committed step in sterol synthesis. Unlike
in mammalian cells, S. pombe Ins1 regulates the activity and not
stability of Hmg1 (Burg et al., 2008).
As in fission yeast, A. fumigatus contains a membrane bound
SREBP homolog, SrbA, required for sterol biosynthesis, hypoxia
fitness, iron homeostasis, and azole drug tolerance/resistance
(Willger et al., 2008; Blatzer et al., 2011; Chung et al., 2014).
The sterol profile of 1srbA shows a significant decrease in total
ergosterol content and accumulation of 4-methyl fecosterol and
4,4 dimethyl fecosterol (Willger et al., 2008; Blosser and Cramer,
2012). This likely stems from direct transcriptional control of
cyp51A/B and erg25A/B expression by SrbA in A. fumigatus
though DNA binding of an SRE motif in their promoters (Blosser
and Cramer, 2012; Chung et al., 2014). Overexpression of cyp51a
in the 1srbA strain does not restore a WT sterol profile or
hypoxia fitness which suggests SrbA regulates multiple steps
in the ergosterol biosynthesis pathway (Figure 1) (Blosser and
Cramer, 2012). In fact, over-expression of cyp51A in 1srbA
exacerbates the accumulation of C4-methyl sterols. However,
intriguingly, this strain’s voriconazole and fluconazole MICs are
restored to WT levels perhaps due to a decrease in toxic 14-α
methylated sterol accumulation (Blosser and Cramer, 2012).
While loss of cyp51a or erg25 is dispensable for virulence of A.
fumigatus, loss of SrbA severely attenuates A. fumigatus virulence
in multiple immune compromised IPA murine models (Mellado
et al., 2005; Alcazar-Fuoli et al., 2006; Blosser and Cramer,
2012; Willger et al., 2008, 2012). Supporting a partial role for
accumulation of C4 methyl sterols as a mechanism to explain the
hypoxia fitness defect of1srbA, generation of an erg25A/B double
genetic null mutant was not possible in A. fumigatus (Blosser
et al., 2014). It is thus possible that accumulation of 4-methyl
sterols in the absence of SrbA contributes in part to its inability to
grow in hypoxia and cause invasive disease. It would be intriguing
to examine the sterol profile of1srbA in the presence of high iron
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levels where a small but significant restoration of hypoxia growth
occurs (Blatzer et al., 2011). Further studies are needed to fully
define SrbA’s role in A. fumigatus hypoxia fitness and virulence.
Intriguingly and worth consideration for therapeutic
development, it is clear that significant differences exist in
SREBP regulation between mammals, the yeast S. pombe, and
the human pathogen A. fumigatus. The difference in SREBP
activation mechanisms in A. fumigatus is highlighted by the
observation that a homolog of SCAP is absent in the A. fumigatus
genome. Moreover, significant levels of the N terminal bHLH
portion of SrbA are detectable in normoxia conditions in
A. fumigatus suggesting that proteolytic cleavage occurs at
some level when sterols levels are presumably high. It is worth
noting that under these conditions NGFP::SrbA localizes to the
ER/NE rather than nuclei (Willger et al., 2012). It is plausible
that post-translational mechanisms control the levels of active
SrbA, in a manner similar to S. pombe (Hughes and Espenshade,
2008), however, this hypothesis needs further investigation.
These observations raise an important question that remains
to be answered in A. fumigatus: how does the A. fumigatus
SREBP pathway monitor cellular sterol levels? It is plausible that
a SCAP like protein remains to be identified. A protein with
sequence similarity to mammalian Insig – InsA (AFUB_064770)
is present in the genome but is yet to be characterized in A.
fumigatus. Moreover, it is plausible that sterol levels fluctuate
with filamentous fungal development in batch culture perhaps
explaining the apparent constitutive cleavage of A. fumigatus
SrbA in sterol replete conditions. Intriguingly, mRNA levels of
SrbA do not change in the presence of voriconazole in at least 2
independent studies (da Silva Ferreira et al., 2006; Krishnan et al.,
2013). This is noteworthy as SrbA has been observed to bind its
own promoter in response to hypoxia and azole drug treatment
(Chung et al., 2014; Gsaller et al., 2016). Thus, it is also plausible
that SrbA activity in A. fumigatus is regulated by another signal
related to oxygen and antifungal drug responses. Given that genes
encoding key enzymes in heme biosynthesis are transcriptionally
regulated by SrbA, heme or heme intermediates are a potential
possibility through which SrbA activity is regulated that remains
to be explored (Davies and Rine, 2006; Chung et al., 2014).
An additional important mechanistic difference in regulation
of SREBP activity in S. pombe and A. fumigatus compared to
mammalian cells is at the level of proteolytic cleavage. S. pombe
and A. fumigatus SREBP pathways lack homologs of S1p and
S2p. Sre1 is activated by a different mechanism requiring golgi
resident defective in sre1 cleavage (Dsc) proteins which form a
complex collectively referred to as the Dsc complex that encode
components of an E3 ligase (Stewart et al., 2011). Homologs of
S. pombe Dsc1-4 are present in the A. fumigatus genome (dscA-
D) and genetic null mutants largely phenocopy the A. fumigatus
srbA genetic null mutant including important azole drug and
virulence phenotypes (Willger et al., 2012). For example, loss of
DscA significantly reduces SrbA N terminus protein levels in
normoxia and hypoxia and mRNA levels of known SrbA target
genes including cyp51A. Phenotypes of 1dscA could largely be
rescued by ectopic expression of the SrbA N terminus, amino acid
residues 1-425. These data link Dsc proteins with regulation of
SrbA function in A. fumigatus.
Recently, a homolog of S. pombe Dsc5, another component
of the Dsc complex, was characterized (dscE) in A. nidulans and
showed to be essential for low oxygen survival in this model
organism. A. nidulans dscE has a UAS and UBX domain at the C
terminus, similar to S. pombe Dsc5 (Stewart et al., 2012; Bat-Ochir
et al., 2016). Interestingly, non-sense mutation in UAS domain
of dscE results in loss of function of this key hypoxia regulator
indicating a role of the UAS and possibly downstream UBX
domain of DscE in hypoxia fitness, similar to the mechanism
of Sre1 cleavage in S. pombe (Bat-Ochir et al., 2016). The UBX
domain is known to interact with Cdc48, a major regulator
of the Endoplasmic Reticulum Associated Degradation (ERAD)
pathway (reviewed in Stolz et al., 2011). In S. pombe, the UBX
domain of Dsc5 is essential for recruitment of Cdc48 to Dsc2,
a component of the Dsc complex; however, this recruitment is
intriguingly dispensable for Sre1 cleavage (Stewart et al., 2012).
It is worth noting that loss of Cdc48 is indispensable for Sre1
cleavage in S. pombe. Thus, further studies are needed to confirm
if Cdc48 is recruited to other components of the Dsc complex
apart from Dsc2 in a Dsc5-UBX domain independent manner
or if expression and not recruitment is essential for its function
in Sre1 cleavage. At this time, the role of the UAS domain of
Dsc5/DscE is not completely understood. Future studies will
determine if the UAS domain has a role in recruitment of Cdc48
or association of Dsc5 to other components of Dsc complex.
Consequently, the mechanism of Sre1 and SrbA cleavage
remains to be fully elucidated. Recently, a rhomboid protease
Rbd2 has been suggested to be necessary for cleavage and
activation of Sre1 in S. pombe (Kim et al., 2015). Further
mechanistic studies are necessary to determine the exact role
of Rbd2 and other yet unidentified mechanisms for cleavage
and activation of Sre1 in fission yeast. Recently two proteases
including an Rbd2 homolog – rbdB and sppA - have been
identified in Neurospora crassa and A. fumigatus mediating the
cleavage of SrbA (Figure 2) (Bat-Ochir et al., 2016; Dhingra
et al., 2016; Vaknin et al., 2016). How SrbA interacts with
the Dsc complex, RbdB and SppA is an important area of
ongoing research. It is important to note that canonically
both rhomboid protease and aspartyl protease cleave the
intramembrane domains and/or near the N terminal site of
their substrates through regulated intramembrane proteolysis
(Lohi et al., 2004; Ha et al., 2013; reviewed in Sun et al.,
2016). In A. fumigatus both proteases appear essential for SrbA
activation, thus future experiments will reveal if their functions
are conserved or if they act in a non-canonical fashion. It is
important to note that the DscE3 complex and SppA are golgi and
ER resident localized proteins respectively (Stewart et al., 2011;
Willger et al., 2012; Bat-Ochir et al., 2016). Thus, it is unclear if
the processing of nascent SrbA happens in ER or if it is a dynamic
process requiring anterograde and retrograde transport from ER
to golgi and vice versa (Figure 2). Additionally, in mammals,
SREBP cleavage in the ER lumen by S1P is a prerequisite for
S2P activity, thus additional, yet unidentified, proteases may be
involved in activation of SrbA (reviewed in Sun et al., 2016). As
mammals and A. fumigatus have a distinct mechanism of SREBP
activation, molecular dissection of SrbA proteolytic cleavage in
A. fumigatus is an important area of future investigation to fully
Frontiers in Microbiology | www.frontiersin.org 5 February 2017 | Volume 8 | Article 92
fmicb-08-00092 January 30, 2017 Time: 15:15 # 6
Dhingra and Cramer Sterol Biosynthesis Regulation Aspergillus fumigatus
FIGURE 2 | Proposed Model of SREBP regulation in A. fumigatus. SrbA (full length SrbA protein is represented as N terminus and C terminus joined by a
transmembrane region) is an ER resident protein, however, the membrane topology of SrbA is unknown. Unlike Schizosaccharomyces pombe, SCAP has not been
identified in A. fumigatus, and it is not clear if an unidentified ER resident protein “X” forms a complex with SrbA to regulate SrbA activation. Golgi resident Dsc
proteins (DscA-E collectively known as DSC complex) are indispensable for SrbA cleavage and activation, however, it is unclear if there is anterograde and/or
retrograde movement of SrbA to the Golgi or Dsc complex movement to the ER for SrbA cleavage. The rhomboid protease RbdB is indispensable for A. fumigatus
cleavage and in S. pombe Rbd2 interacts with the UBX domain of Dsc5 (DscE homolog of A. fumigatus) via Cdc48. However, the nature of this interaction needs
validation in A. fumigatus. The Signal Peptide Peptidase (SppA) is an ER resident aspartyl protease involved in regulated intramembrane proteolysis and is
indispensable for SrbA cleavage, however, it is not clear if SppA cleavage is preceded or followed by action of the Dsc complex and/or RbdB mediated cleavage.
Once cleaved, the C terminus of the protein is potentially degraded and the N terminus translocates to the nucleus where it binds to SRE elements in the promoter
region of genes involved in the hypoxia response. SrbA also positively regulates its own mRNA levels by binding the SRE element in the promoter region of srbA.
Solid lines depict experimentally validated results, whereas dotted lines indicate predicted but not experimentally tested mechanisms. X – Unknown ER resident
protein or unidentified SCAP (like) homolog.
understand sterol biosynthesis and harness this pathway for novel
therapeutic development.
Regulation of SREBPs in other fungi is complex and
involves additional regulatory layers including post-translational
mechanisms that could potentially be unique to filamentous
fungi. These mechanisms are high priority targets for
investigation in A. fumigatus. For example, a second non-
sterol dependent pathway also controls levels of Sre1 in S. pombe.
When oxygen concentration is high, a prolyl 4-hydroxylase-like
2-oxoglutarate-Fe(II) dioxygenase Ofd1 negatively regulates
Sre1N levels in a proteasome dependent manner (Hughes and
Espenshade, 2008). Under low oxygen concentrations another
protein, Negative Regulator of Ofd1 – Nro1, binds to the C
terminal degradation domain of Ofd1 and prevents Sre1N
degradation leading to stability and accumulation of Sre1N
in cells (Lee et al., 2009). It is interesting to note that while a
putative homolog of Ofd1 is present in the A. fumigatus genome
and remains to be characterized, a homolog of Nro1 is not
present bringing into question whether this elegant regulatory
mechanism is in play for SrbA regulation.
In mammals, SREBP TF levels and function are also controlled
by post-translational modifications and this remains a promising
area of investigation in A. fumigatus. In mammalian cells,
GSK-3 (glycogen-synthase kinase) phosphorylates SREBP1 in
response to DNA binding. GSK-3 mediated phosphorylation
leads to docking of the ubiquitin ligase FBW7 on phosphorylated
residues and subsequent proteasome-mediated degradation of
active SREBP TFs (Sundqvist et al., 2005; Punga et al., 2006;
Bengoechea-Alonso and Ericsson, 2009). Thus, in A. fumigatus,
levels of active SrbA may be regulated through phosphorylation
by GSK-3 and/or a different kinase followed by proteasome
mediated degradation. This hypothesis awaits testing though is
particularly attractive given the plethora of kinase inhibitors
available to explore for antifungal development.
Another important area for investigation is the relationship
between multiple SREBP genes in A. fumigatus and sterol
biosynthesis. Similar to the mammalian SREBP pathway, three
SREBPs have been identified in A. fumigatus – SrbA, SrbB,
and SrbC (Willger et al., 2008; Chung et al., 2014). A second
SREBP, Sre2, is present in S. pombe. Sre2 contains the hallmark
tyrosine residue in the bHLH DNA binding domain, and two
transmembrane domains however, Sre2 does not bind Scp1
and is not regulated by levels of sterols. Interestingly, Sre2
is constitutively cleaved and requires the Dsc complex for
processing (Hughes et al., 2005; Stewart et al., 2011). However,
loss of Sre2 does not appear to affect hypoxia fitness in S. pombe.
Further studies are needed to determine the role and targets of
Sre2 in S. pombe.
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In A. fumigatus, SrbB and SrbC both have the canonical
tyrosine residue in the bHLH DNA binding domain but lack
the predicted transmembrane and C terminal domains of SrbA.
SrbB mRNA levels are massively induced in response to hypoxia
through an unknown mechanism. SrbA contributes in part to
srbB hypoxia mRNA levels through direct binding to the srbB
promoter region (Chung et al., 2014). However, loss of SrbA
does not completely attenuate srbB mRNA levels. Importantly,
loss of SrbB in A. fumigatus attenuates low oxygen fitness and
virulence but not tolerance to azole antifungal drugs. Direct
target genes of SrbB remain to be elucidated, but initial studies
suggest it contributes to regulation of erg25A and hem13 mRNA
levels. Importantly, SrbB is a critical regulator of the ethanol
fermentation pathway through direct regulation of the alcohol
dehydrogenase alcC mRNA levels (Grahl et al., 2011; Chung et al.,
2014). SrbC is expressed at low levels in conditions examined
to date including low oxygen and its role in sterol biosynthesis
and SREBP gene regulation are under investigation (Chung et al.,
2014).
An important area of future research is determining how the 3
SREBPs coordinate target gene expression which is expected to
yield novel insights into the role of these TFs in A. fumigatus
biology and pathogenesis. There at least appears to be co-
regulation of the key ergosterol biosynthetic genes erg1 and
erg25A by SrbA and SrbB (Chung et al., 2014). In mammals,
hetero-dimerization of SREBPs controls regulation of SRBEP
target genes (Datta and Osborne, 2005). Whether this co-
regulation of sterol biosynthesis genes observed in A. fumigatus
involves heterodimer formation between SrbA and SrbB is not
known, and direct regulation of SrbB by SrbA and vice-versa
cannot be ruled out and is likely. It is interesting to note the
presence of a canonical SRE in the promoter region of SrbA
and data suggest SrbA auto-regulates its mRNA levels (Chung
et al., 2014). Further research will elucidate if binding of different
SREBPs to the SRE element in the promoter region of SrbA
confer differential protein regulation for activation of SrbA under
hypoxic and sterol-level mediated stress. In general, rigorous
promoter analysis of critical genes in ergosterol biosynthesis
remains an important but understudied area of A. fumigatus
biology.
Regulation of Cytochrome P450
Enzymes
Cytochrome P450 enzymes are heme dependent monooxyge-
nases and represent an important class of enzymes for normal
levels of ergosterol production (and some enzymes in this class
are the major targets of the azole class of anti-fungal drugs as
previously discussed (reviewed in Nebert and Russell, 2002)).
Two major cytochrome P450 heme containing enzymes are
present in the ergosterol biosynthesis pathway viz., Erg5 and
Erg11 (Cyp51) (Song et al., 2016). Despite their importance
in sterol synthesis and removal of toxic sterol intermediates,
cytochrome b5 and P450 oxidoreductase are the only known
proteins that interact with and control the levels of cytochrome
P450 enzymes (Hughes et al., 2007b; reviewed in Pandey and
Flück, 2013; reviewed in Schenkman and Jansson, 2003). In
fission yeast, the damage response protein Dap1 physically
interacts with both Erg5 and Erg11 and is necessary for normal
sterol levels (Hughes et al., 2007b). This physical interaction
requires heme binding and a stable complex formation between
Dap1 and P450 enzymes. Mutant cells lacking Dap1 accumulate
sterol intermediates and lower levels of ergosterol (Hughes et al.,
2007b).
In A. fumigatus, sequence similarity searches led to the
identification and characterization of three Dap proteins,
DapA-C with antagonistic functions. A DapA null mutant is
hypersensitive to itraconazole, whereas a DapC null mutant is
more resistant compared to the wild type strain. This sensitivity
may stem from the fact that abnormal levels of sterols accumulate
in Dap genetic null mutants. A DapA null mutant accumulates
lower ergosterol levels and a subsequent increase in levels of
ergosta-5,7,24(28)- trienol and ergosta 5,7 dienol indicating a
blockage at Erg5 (cytochrome p450 desaturase) (Figure 1). The
current model of Dap protein mediated regulation of sterol
biosynthesis suggests DapA is necessary for stability of Erg5 and
Cyp51A and loss of DapA leads to degradation of Cyp51B. Heme
binding may be critical for DapA mediated stability of Erg5 and
Cyp51A but not Cyp51B. Where DapA is necessary for function
of P450 enzymes, DapB and DapC have antagonistic role through
iron binding. DapB and DapC are predicted to irreversibly bind
iron affecting the local iron concentration and thereby altering
heme-dependent P450 enzyme function (Song et al., 2016). The
presence of multiple Dap proteins with antagonistic functions
allows complex regulation between sterol synthesis and iron
availability. As Dap proteins control levels of P450 enzymes,
targeting DapA might provide a novel therapeutic target to treat
azole resistant cases of IA and or potentiate the efficacy of existing
triazoles targeting Cyp51 enzymes.
ER Stress and Sterol Levels
Stress conditions can overwhelm ER capacity to correctly fold
proteins that are destined for the membrane and cytosol.
Perturbation in lipid synthesis is known to activate the Unfolded
Protein Response (UPR) in S. cerevisiae and A. fumigatus (Pineau
et al., 2009; Han et al., 2010; reviewed in Volmer and Ron, 2015).
The UPR pathway alleviates ER stress by balancing the proteins
entering the ER for folding and the rate of ER protein folding
capacity (reviewed in Moore and Hollien, 2012). Proteins that
fail to fold correctly are degraded by a proteasome-mediated
degradation pathway called ER-associated degradation (ERAD)
(reviewed in Tsai and Weissman, 2010; reviewed in Wang
and Kaufman, 2014). Mutants defective in ERAD constitutively
activate the UPR, indicating regulatory crosstalk between these
two pathways (Travers et al., 2000). A. fumigatus detects ER
stress via the ER stress sensor IreA, which activates HacA –
the major regulator of the UPR (Feng et al., 2011). Ergosterol
levels are negatively affected in both ireA and hacA null mutants
and sterol intermediates accumulate in 1hrdA, a strain with a
deficient ERAD pathway (Feng et al., 2011; Krishnan et al., 2013).
This increase in sterol intermediates in 1hrdA might be the
result of HMG CoA reductase turnover as Hrd1 is required for
degradation of HMG CoA reductase in yeast (Hampton et al.,
1996). Interestingly,1hrdA is resistant to voriconazole compared
to the WT strain, although mRNA levels of cyp51A and cyp51B
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are not different in these two strains (Krishnan et al., 2013).
While the ERAD pathway appears dispensable for virulence in A.
fumigatus, mutants that lack the UPR regulators ireA and hacA
show significant virulence attenuation in murine models of IPA
(Richie et al., 2009; Feng et al., 2011; Krishnan et al., 2013).
Intriguingly, like the SREBP pathway, the UPR is involved in
hypoxia and iron stress responses in A. fumigatus (Feng et al.,
2011; reviewed in Grahl et al., 2012; reviewed in Krishnan and
Askew, 2014). This raises an interesting question of interplay
between the UPR and SREBP activation in A. fumigatus given
also that SrbA is an ER resident protein. It is not clear if
SREBP activation requires the UPR, as hypoxia is known to
activate UPR in tumors (Feldman et al., 2005; reviewed in
Romero-Ramirez et al., 2004; Koumenis and Wouters, 2006).
In support of this hypothesis, a mechanism by which the UPR
is activated in response to lipid stress is different compared
to protein misfolding activation, and ireA mediated hypoxia
fitness is hacA independent in A. fumigatus (Feng et al., 2011;
Lajoie et al., 2012). As UPR mutants 1hacA and 1ireA have
increased sensitivity to azoles and reduced total ergosterol
content (Richie et al., 2009; Feng et al., 2011), future research
should elucidate whether the role of UPR in mediating azole
sensitivity is SREBP dependent or independent. Also, the role of
the UPR pathway in azole resistance needs further exploration.
This provides a novel genetic opportunity to decipher the link
between the UPR, SREBPs and lipid homeostasis and highlights
a potential therapeutic opportunity to target the UPR and/or
SREBP pathway in A. fumigatus.
Iron Levels Regulate Ergosterol Levels in
A. fumigatus
Iron is a major cofactor for essential life processes and is
indispensable for growth of microbes including A. fumigatus
(reviewed in Chung et al., 2012; reviewed in Haas, 2012; reviewed
in Kaplan and Kaplan, 2009). Microbes have elegant strategies
to acquire iron under iron deplete conditions such as in the
tissue microenvironments of the host (Schrettl et al., 2007,
2008). Under these conditions, A. fumigatus relies mainly on
siderophore production for iron acquisition (Schrettl et al., 2004).
SrbA is required for production of siderophores and fitness in
low iron liquid environments (Blatzer et al., 2011). There is
a direct correlation between iron availability and sterol levels
in A. fumigatus and this is mediated in part by SrbA (Blatzer
et al., 2011; Yasmin et al., 2012). Mevalonate is a key metabolic
intermediate between ergosterol and siderophore production,
and its fate is dependent on iron availability. Under iron replete
conditions, mevalonate is preferentially converted to ergosterol,
however, in iron deplete conditions mevalonate is converted to
the siderophore TAFC. In iron deplete conditions, ergosterol
levels are reduced by ∼50% and sterol intermediates accumulate
rendering A. fumigatus more sensitive to voriconazole (Yasmin
et al., 2012). Consequently, these data suggest that HMG CoA
reductase is a potential target for treatment of IA. Cholesterol
lowering agents known as statins target HMG CoA reductase
(reviewed in Tobert, 2003). Statins have fungicidal activity
against A. fumigatus, however at concentrations higher than
safe physiological levels used to control cholesterol in humans
(Qiao et al., 2007). In plants, bacteria and protozoa, a non-
mevalonate pathway (NMP) exists for isoprenoid biosynthesis
(reviewed in Hunter, 2007; Odom, 2011). As NMP is not reported
in A. fumigatus and homologs of enzymes in NMP are absent
in A. fumigatus, modifying current statins or development of
new drugs to target mevalonate production at clinically relevant
concentrations needs further exploration.
AZOLE DRUG RESISTANCE IN
A. fumigatus
Aspergillus fumigatus resistance to azoles was first reported in
1997 (Denning et al., 1997), and is an emerging area of major
concern in the fight against aspergillosis (reviewed in Mayr and
Lass-Flörl, 2011). Azole resistant isolates have been reported
in Europe, Middle east, Asia, Africa, Australia and the USA
(Wiederhold et al., 2016). Molecular genotyping has revealed use
of azole based fungicides to protect plants as a possible route
of azole resistant A. fumigatus environmental isolate emergence
(Snelders et al., 2009). The dominant resistance mechanism
conferring resistance to pan-azole drugs consists of mutations
in cyp51A, most notably at positions 54, 98, 138, 220 and 448
(reviewed in Denning and Perlin, 2011; Choi et al., 2014). These
point mutations may alter the binding affinity of azoles to
Cyp51A (reviewed in Parker et al., 2014). Along with mutations
in the amino acid encoding region, the presence of tandem
repeats (TR) in the untranslated region (UTR) of cyp51A also
drives an increase in cyp51A levels (Figure 3) (Snelders et al.,
2011; Gsaller et al., 2016). Various tandem repeats have been
identified in the UTR of cyp51 viz., TR34, TR46 and TR53. TR34
and TR46 are often found in association with mutations in
the cyp51A gene and the most commonly detected resistance
categories to date are TR34/L98H, TR46/Y121F/T289A (reviewed
in Verweij et al., 2016).
A second azole resistance mechanism affecting cyp51 mRNA
levels, exists in A. fumigatus. Whole genome sequencing (WGS)
of isolates that acquired de novo azole resistance revealed a
mutation in the hapE gene causing a P88L mutation in the amino
acid sequence (Camps et al., 2012). HapE, along with HapB and
HapC, is a subunit of the CCAAT binding transcription factor
complex (CBC) (Hortschansky et al., 2015). A CGAAT motif is
present in the 5′ UTR of cyp51A of A. fumigatus and the P88L
mutation in HapE increases expression of cyp51A in A. fumigatus
(Gsaller et al., 2016).
Recently, an additional understanding of the molecular
mechanisms of TR34 associated azole resistance was elucidated.
In an azole resistant strain with the TR34 mutation, the
duplication of the tandem repeat (TR) causes duplication
of SREs in the UTR of cyp51A. SrbA binding to SREs in
the TR is responsible for increased mRNA levels of cyp51A.
However, the CBC, which canonically binds the CCAAT motif,
binds a degenerate CGAAT motif in the UTR of cyp51 and
negatively regulates its expression. Consequently, in strains with
a mutation in the HapE subunit (HapEP88L), CBC binding to
the CGAAT motif is significantly reduced allowing increased
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FIGURE 3 | Regulation of cyp51A expression in A. fumigatus. In azole
susceptible isolates, two SRE elements and one CBC binding motif is present
in the promoter region of cyp51A. Binding of SrbA to SREs positively
regulates cyp51A expression while binding of the CBC to the CGAAT motif
negatively regulates expression. Azole challenge (arrow) also positively
regulates cyp51a expression. In strains containing either a TR34 promoter
repeat or TR46 promoter repeat, SRE elements and CBC binding motifs are
duplicated and SrbA effectively binds SREs in the duplicated region, thereby
increasing cyp51A expression. Mutation in the HapE (P88L) subunit of the
CBC lowers the affinity of the CBC to the CGAAT motif thereby inhibiting
negative regulation of cyp51A expression. Solid lines depict experimentally
validated results, whereas dotted lines indicate hypotheses which need further
validation. Importantly, additional regulatory factors are likely in play at this
important gene promoter.
SrbA SRE binding and increased levels of cyp51A. Expression
of cyp51A is further increased when the TR duplicate is present
increasing SRE motifs in the cyp51A UTR region (Figure 3). Not
surprisingly given its role in direct regulation of cyp51A levels,
loss of SrbA in a TR34 azole resistant strain reverses the resistance
to azoles and thus provides a potential target to increase the
efficacy of azoles against resistant strains (Willger et al., 2008;
Blosser and Cramer, 2012; Gsaller et al., 2016).
It is not known at this time if regulation of cyp51A, a heme-
iron containing enzyme, by the CBC is iron dependent. It is
fair to speculate that under iron deplete conditions the CBC
will down-regulate cyp51 expression, thereby optimizing levels
of ergosterol and siderophore production under iron deplete
conditions. As stated above under low iron conditions, formation
of TAFC is favored over ergosterol. This provides a complex layer
of regulation and cross talk between iron acquisition and sterol
biosynthesis pathways in Aspergillus fumigatus that is dependent
on hapX, the CBC, cyp51, DAP proteins, and SrbA. Other recently
reported azole resistance mechanisms include overexpression
of cyp51A, point mutations in cyp51B and over expression of
drug transporters leading to eﬄux of drugs (reviewed in Parker
et al., 2014). The molecular dissection of the TF interplay at
the cyp51A promoter is an important advance in understanding
azole-Aspergillus interactions and warrants further in depth
investigation into the factors involved in controlling this critical
step in ergosterol biosynthesis.
Recently, an elegant approach that utilized the sexual cycle
of A. fumigatus identified additional novel loci associated with
azole drug resistance. Losada et al. (2015) identified mutations
in cyp51A, multi-drug transporters, HMG-CoA reductase and
interestingly erg25 from an in vitro drug selection experiment.
In addition, Abdolrasouli et al. (2015) recently used a WGS
approach to better understanding azole resistance mechanisms in
a panel of 24 isolates collected across geographic locations. Their
study further emphasizes the power of WGS to identify potential
azole resistance mechanisms and paves the way for robust
genome-wide association (GWAS) studies in this important
human pathogen.
Role of Hsp90
Hsp90 is molecular chaperone that regulates diverse client
proteins, many of which are involved in cell signaling (Cowen
and Lindquist, 2005). Hsp90 is conserved across eukaryotes
and gene deletion strategies reveal it is necessary for survival
in A. fumigatus (Lamoth et al., 2014). In S. cerevisiae and C.
albicans, Hsp90 function is critical for the emergence of azole
resistance. Hsp90 mediated azole resistance is associated with loss
of erg3 function, leading to accumulation of ergosta-7,22-dienol
in C. albicans. This prevents accumulation of toxic 14-α-methyl-
3,6-diol. This allows, alternatively, 14-α methyl fecosterol to
incorporate into the membrane and circumvent cyp51 mediated
azole activity (Martel et al., 2010; reviewed in Shapiro et al.,
2011). Thus, it is plausible that Hsp90 directly or indirectly affects
the ergosterol biosynthetic pathway in A. fumigatus. Mutagenesis
experiments revealed deacetylation of K27 is necessary for Hsp90
mediated azole resistance in A. fumigatus, however no positive
interaction was observed between a lysine deacetylase inhibitor
and azole drugs in A. fumigatus (Lamoth et al., 2014). As erg3
associated azole resistance is reported for C. albicans (Kelly
et al., 1997) and has not been identified or reported in clinical
azole resistance strains of A. fumigatus to date, further research
is needed to determine the role of Hsp90 on long-term azole
therapies for IA and to completely understand the role of Hsp90
in azole mediated drug resistance.
FUTURE DIRECTIONS
The combination of the increasing incidence of aspergillosis
across multiple diverse patient populations and the emergence
of azole drug resistance highlights the need for therapeutic
advances. More in depth research is needed on mechanisms
of sterol biosynthesis in A. fumigatus given its importance in
fungal viability and interactions with clinically relevant antifungal
drugs. A common theme in the mechanisms of sterol biosynthesis
studied to date is the need for oxygen and iron highlighted by the
critical role of the hypoxia and sterol biosynthesis transcriptional
regulator SrbA and co-regulatory factors such as the CBC. Given
the critical role of SrbA in drug tolerance and susceptibility and
its virulence profile in vivo, a unique opportunity exists to harness
this pathway for therapeutic development (Willger et al., 2008).
While many approaches are feasible, one inexpensive and
clinically available approach is to test the hypothesis that
alleviating tissue hypoxia can improve disease outcomes through
alteration of the SrbA pathway in vivo. HBO (100% O2
at 2.5–3.5ATA) has been used clinically to treat hypoxia
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and increase oxygen levels in tissues in multiple disease settings
(Kurt et al., 2015; Kolpen et al., 2016; reviewed in Thom, 2011).
Importantly, multiple lines of evidence and preliminary results
suggest synergy between HBO and action of anti-fungal drugs in
some disease settings (Garcia-Covarrubias et al., 2002; John et al.,
2005; Segal et al., 2007). It is important to note that MIC’s of
azoles including voriconazole against A. fumigatus were similar
under normoxic and hypoxic conditions (Binder et al., 2015).
This might be because SREBPs have evolved to sense sterol levels,
thus increasing expression of ergosterol biosynthetic genes under
hypoxic conditions (Blosser and Cramer, 2012; Chung et al.,
2014). It is plausible that HBO can directly inhibit activation of
the SrbA pathway in vivo in A. fumigatus and thereby enhance
the efficacy of azole antifungal drugs, overcome SrbA mediated
drug resistance due to over expression of cyp51A (Figure 3)
(Gsaller et al., 2016), and mitigate fungal proliferation. Ergosterol
can regulate its own levels through negative feedback regulation
in S. cerevisiae (Casey et al., 1992). Thus, it is possible that
under HBO conditions, increased ergosterol levels would inhibit
the pathway and increase sensitivity to azoles. Future research
should determine the sterol profile under HBO conditions and
if differential sterol profiles play a role in the observed synergy
between HBO and anti-fungal drugs in some species. It is possible
HBO targets an additional pathway which compliments the
targeting of ergosterol. HBO has been shown to increase oxygen
free radicals and can increase the activity of immune cells against
fungal infections (Almzaiel et al., 2013). HBO is also known to
increase angiogenesis and play a role in wound healing (reviewed
in Moen and Stuhr, 2012). While HBO may or may not prove
to be clinically relevant in the context of IPA, similar approaches
to alter the induction of genetic networks critical for sterol
biosynthesis and azole drug susceptibility is an important and
exciting area of future research.
Other potential therapeutic options include prevention of
SrbA cleavage and activation through a direct targeting approach.
The genetic null mutants of the strains lacking srbA, members of
the Dsc complex and proteases encoding rbdB and sppA genes
phenocopy the srbA null mutant (Willger et al., 2008, 2012;
Bat-Ochir et al., 2016; Dhingra et al., 2016). Thus, screening
and identification of small molecules that prevent cleavage and
activation of SrbA either by binding the regulatory proteins or
inhibiting protein-protein interactions may prove to be beneficial
in achieving successful outcomes for IPA. To achieve these goals,
additional research is needed to provide a deeper understanding
of the underlying molecular mechanisms to identify therapeutic
opportunities.
AUTHOR CONTRIBUTIONS
All authors listed, have made substantial, direct and intellectual
contribution to the work, and approved it for publication.
FUNDING
This work, including the efforts of RC, was funded by HHS (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
(R01AI081838). RC holds an Investigators in the Pathogenesis
of Infectious Disease Award from the Burroughs Wellcome
Fund. SD was supported in part by a Cystic Fibrosis Research
Development Program Award (STANTO07R0).
REFERENCES
Abdolrasouli, A., Rhodes, J., Beale, M. A., Hagen, F., Rogers, T. R., Chowdhary, A.,
et al. (2015). Genomic context of azole resistance mutations in Aspergillus
fumigatus determined using whole-genome sequencing. MBio 6:e00536. doi:
10.1128/mBio.00536-15
Abraham, O. C., Manavathu, E. K., Cutright, J. L., and Chandrasekar, P. H. (1999).
In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and
amphotericin B. Diagn. Microbiol. Infect. Dis. 33, 7–11. doi: 10.1016/S0732-
8893(98)00102-3
Alcazar-Fuoli, L., Mellado, E., Garcia-Effron, G., Buitrago, M. J., Lopez, J. F.,
Grimalt, J. O., et al. (2006). Aspergillus fumigatus C-5 sterol desaturases Erg3A
and Erg3B: role in sterol biosynthesis and antifungal drug susceptibility.
Antimicrob. Agents Chemother. 50, 453–460. doi: 10.1128/AAC.50.2.453-460.
2006
Alcazar-Fuoli, L., Mellado, E., Garcia-Effron, G., Lopez, J. F., Grimalt, J. O.,
Cuenca-Estrella, J. M., et al. (2008). Ergosterol biosynthesis pathway in
Aspergillus fumigatus. Steroids 73, 339–347. doi: 10.1016/j.steroids.2007.
11.005
Almzaiel, A. J., Billington, R., Smerdon, G., and Moody, A. J. (2013). Effects
of hyperbaric oxygen treatment on antimicrobial function and apoptosis of
differentiated HL-60 (neutrophil-like) cells. Life Sci. 93, 125–131. doi: 10.1016/
j.lfs.2013.06.003
Apel, K., and Hirt, H. (2004). Reactive oxygen species: metabolism, oxidative stress,
and signal transduction. Annu. Rev. Plant Biol. 55, 373–399. doi: 10.1146/
annurev.arplant.55.031903.141701
Bard, M., Lees, N. D., Turi, T., Craft, D., Cofrin, L., Barbuch, R., et al. (1993). Sterol
synthesis and viability of erg11 (cytochrome P450 lanosterol demethylase)
mutations in Saccharomyces cerevisiae and Candida albicans. Lipids 28, 963–
967. doi: 10.1007/BF02537115
Bat-Ochir, C., Kwak, J. Y., Koh, S. K., Jeon, M. H., Chung, D., Lee, Y. W., et al.
(2016). The signal peptide peptidase SppA is involved in sterol regulatory
element-binding protein cleavage and hypoxia adaptation in Aspergillus
nidulans. Mol. Microbiol. 100, 635–655. doi: 10.1111/mmi.13341
Bengoechea-Alonso, M. T., and Ericsson, J. (2009). A phosphorylation cascade
controls the degradation of active SREBP1. J. Biol. Chem.. 284, 5885–5895.
doi: 10.1074/jbc.M807906200
Benveniste, P. (2004). Biosynthesis and accumulation of sterols. Annu. Rev. Plant
Biol. 55, 429–457. doi: 10.1146/annurev.arplant.55.031903.141616
Bergren, D. R., and Beckman, D. L. (1975). Hyperbaric oxygen and pulmonary
surface tension. Aviat. Space Environ. Med. 46, 994–995.
Binder, U., Maurer, E., Lackner, M., and Lass-Flörl, C. (2015). Effect of
reduced oxygen on the antifungal susceptibility of clinically relevant Aspergilli.
Antimicrob. Agents Chemother. 59, 1806–1810. doi: 10.1128/AAC.04204-14
Blatzer, M., Barker, B. M., Willger, S. D., Beckmann, N., Blosser, S. J., Cornish, E. J.,
et al. (2011). SREBP coordinates iron and ergosterol homeostasis to mediate
triazole drug and hypoxia responses in the human fungal pathogen Aspergillus
fumigatus. PLoS Genet. 7:e1002374. doi: 10.1371/journal.pgen.1002374
Blosser, S. J., and Cramer, R. A. (2012). SREBP-dependent triazole susceptibility
in Aspergillus fumigatus is mediated through direct transcriptional regulation
of erg11a (cyp51a). Antimicrob. Agents Chemother. 56, 248–257. doi: 10.1128/
AAC.05027-11
Blosser, S. J., Merriman, B., Grahl, N., Chung, D., and Cramer, R. A. (2014).
Two C4-sterol methyl oxidases (Erg25) catalyse ergosterol intermediate
demethylation and impact environmental stress adaptation in Aspergillus
fumigatus. Microbiology 160, 2492–2506. doi: 10.1099/mic.0.080440-0
Frontiers in Microbiology | www.frontiersin.org 10 February 2017 | Volume 8 | Article 92
fmicb-08-00092 January 30, 2017 Time: 15:15 # 11
Dhingra and Cramer Sterol Biosynthesis Regulation Aspergillus fumigatus
Brown, A. J., Sun, L., Feramisco, J. D., Brown, M. S., and Goldstein, J. L. (2002).
Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP
escort protein that regulates cholesterol metabolism. Mol. Cell. 10, 237–245.
doi: 10.1016/S1097-2765(02)00591-9
Brown, G. D., Denning, D. W., Gow, N. A., Levitz, S. M., Netea, M. G., and
White, T. C. (2012). Hidden killers: human fungal infections. Sci. Transl. Med.
4:165rv13. doi: 10.1126/scitranslmed.3004404
Brown, M. S., Dana, S. E., and Goldstein, J. L. (1973). Regulation of 3-
hydroxy-3-methylglutaryl coenzyme a reductase-activity in human fibroblasts
by lipoproteins. Proc. Natl. Acad. Sci. U.S.A. 70, 2162–2166. doi: 10.1073/pnas.
70.7.2162
Brown, M. S., and Goldstein, J. L. (1986). A receptor-mediated pathway for
cholesterol homeostasis. Science 232, 34–47. doi: 10.1126/science.3513311
Brown, M. S., and Goldstein, J. L. (1997). The SREBP pathway: regulation of
cholesterol metabolism by proteolysis of a membrane-bound transcription
factor. Cell 89, 331–340. doi: 10.1016/S0092-8674(00)80213-5
Buchwald, H., O’Dea, T. J., Menchaca, H. J., Michalek, V. N., and Rohde, T. D.
(2000). Effect of plasma cholesterol on red blood cell oxygen transport. Clin.
Exp. Pharmacol. Physiol. 27, 951–955. doi: 10.1046/j.1440-1681.2000.03383.x
Burg, J. S., Powell, D. W., Chai, R., Hughes, A. L., Link, A. J., and Espenshade,
P. J. (2008). Insig regulates Hmg-coA reductase by controlling enzyme
phosphorylation in fission yeast. Cell Metab. 8, 522–531. doi: 10.1016/j.cmet.
2008.09.004
Camps, S. M., Dutilh, B. E., Arendrup, M. C., Rijs, A. J., Snelders, E., Huynen,
M. A., et al. (2012). Discovery of a HapE mutation that causes azole resistance
in Aspergillus fumigatus through whole genome sequencing and sexual crossing.
PLoS ONE 7:e50034. doi: 10.1371/journal.pone.0050034
Casey, W. M., Keesler, G. A., and Parks, L. W. (1992). Regulation of partitioned
sterol biosynthesis in Saccharomyces cerevisiae. J. Bacteriol. 174, 7283–7288.
doi: 10.1128/jb.174.22.7283-7288.1992
Chang, Y. C., Bien, C. M., Lee, H., Espenshade, P. J., and Kwon-Chung, K. J.
(2007). Sre1p, a regulator of oxygen sensing and sterol homeostasis, is required
for virulence in Cryptococcus neoformans. Mol. Microbiol. 64, 614–629. doi:
10.1111/j.1365-2958.2007.05676.x
Choi, J. Y., Podust, L. M., and Roush, W. R. (2014). Drug strategies targeting
cyp51 in neglected tropical diseases. Chem. Rev. 114, 11242–11271. doi: 10.
1021/cr5003134
Chowdhary, A., Kathuria, S., Xu, J., and Meis, J. F. (2013). Emergence of azole-
resistant Aspergillus fumigatus strains due to agricultural azole use creates an
increasing threat to human health. PLoS Pathog. 9:e1003633. doi: 10.1371/
annotation/4ffcf1da-b180-4149-834c-9c723c5dbf9b
Chung, D., Barker, B. M., Carey, C. C., Merriman, B., Werner, E. R., Lechner,
B. E., et al. (2014). ChIP-seq and in vivo transcriptome analyses of the
Aspergillus fumigatus SREBP SrbA reveals a new regulator of the fungal hypoxia
response and virulence. PLoS Pathog. 10:e1004487. doi: 10.1371/journal.ppat.
1004487
Chung, D., Haas, H., and Cramer, R. A. (2012). Coordination of hypoxia adaptation
and on homeostasis in human pathogenic fungi. Front. Microbiol. 3:381. doi:
10.3389/fmicb.2012.00381
Cowen, L. E., and Lindquist, S. (2005). Hsp90 potentiates the rapid evotution
of new traits: drug resistance in diverse fungi. Science 309, 2185–2189. doi:
10.1126/science.1118370
da Silva Ferreira, M. E., Colombo, A. L., Paulsen, I., and Goldman, G. H.
(2005). The ergosterol biosynthesis pathway, transporter genes, and azole
resistance in Aspergillus fumigatus. Med. Mycol. 43, S313–S319. doi: 10.1080/
13693780400029114
da Silva Ferreira, M. E., Malavazi, I., Savoldi, M., Brakhage, A. A., Goldman,
M. H., Kim, H. S., et al. (2006). Transcriptome analysis of Aspergillus fumigatus
exposed to voriconazole. Curr. Genet. 50, 32–44. doi: 10.1007/s00294-006-
0073-2
Dannaoui, E., Garcia-Hermoso, D., Naccache, J. M., Meneau, I., Sanglard, D.,
Bouges-Michel, C., et al. (2006). Use of voriconazole in a patient with
aspergilloma caused by an itraconazole-resistant strain of Aspergillus fumigatus.
J. Med. Microbiol. 55(Pt. 10), 1457–1459. doi: 10.1099/jmm.0.46639-0
Datta, S., and Osborne, T. F. (2005). Activation domains from both monomers
contribute to transcriptional stimulation by sterol regulatory element-binding
protein dimers. J. Biol. Chem. 280, 3338–3345. doi: 10.1074/jbc.M411222200
Davies, B. S. J., and Rine, J. (2006). A role for sterol levels in oxygen sensing
in Saccharomyces cerevisiae. Genetics 174, 191–201. doi: 10.1534/genetics.106.
059964
Denning, D. W., and Perlin, D. S. (2011). Azole resistance in Aspergillus: a growing
public health menace. Future Microbiol. 6, 1229–1232. doi: 10.2217/fmb.11.118
Denning, D. W., Venkateswarlu, K., Oakley, K. L., Anderson, M. J., Manning, N. J.,
Stevens, D. A., et al. (1997). Itraconazole resistance in Aspergillus fumigatus.
Antimicrob. Agents Chemother. 41, 1364–1368.
Dhingra, S., Kowlaski, C. H., Thammahong, A., Beattie, S. R., Bultman, K. M.,
and Cramer, R. A. (2016). RbdB, a rhomboid protease critical for SREBP
activation and virulence in Aspergillus fumigatus. mSphere 1, e35–e16. doi:
10.1128/mSphere.00035-16
Duncan, E. A., Brown, M. S., Goldstein, J. L., and Sakai, J. (1997). Cleavage site
for sterol-regulated protease localized to a Leu-Ser bond in the lumenal loop of
sterol regulatory element-binding protein-2. J. Biol. Chem. 272, 12778–12785.
doi: 10.1074/jbc.272.19.12778
Duncan, E. A., Davé, U. P., Sakai, J., Goldstein, J. L., and Brown, M. S. (1998).
Second-site cleavage in sterol regulatory element-binding protein occurs at
transmembrane junction as determined by cysteine panning. J. Biol. Chem. 273,
17801–17809. doi: 10.1074/jbc.273.28.17801
Espenshade, P. J. (2006). SREBPs: sterol-regulated transcription factors. J. Cell Sci.
119, 973–976. doi: 10.1242/jcs02866
Espenshade, P. J., and Hughes, A. L. (2007). Regulation of sterol synthesis in
eukaryotes. Annu. Rev. Genet. 41, 401–427. doi: 10.1146/annurev.genet.41.
110306.130315
Feldman, D. E., Chauhan, V., and Koong, A. C. (2005). The unfolded protein
response: a novel component of the hypoxic stress response in tumors. Mol.
Cancer Res. 3, 597–605. doi: 10.1158/1541-7786.MCR-05-0221
Feng, X. Z., Krishnan, K., Richie, D. L., Aimanianda, V., Hart, L., Grah, N., et al.
(2011). HacA-independent functions of the ER stress sensor IreA synergize with
the canonical UPR to influence virulence traits in Aspergillus fumigatus. PLoS
Pathog. 7:e1002330. doi: 10.1371/journal.ppat.1002330
Fryberg, M., Oehlschlager, A. C., and Unrau, A. M. (1973). Biosynthesis of
ergosterol in yeast – evidence for multiple pathways. J. Am. Chem. Soc. 95,
5747–5757. doi: 10.1021/ja00798a051
Galea, A. M., and Brown, A. J. (2009). Special relationship between sterols and
oxygen: were sterols an adaptation to aerobic life? Free Radic. Biol. Med. 47,
880–889. doi: 10.1016/j.freeradbiomed.2009.06.027
Gallis, H. A., Drew, R. H., and Pickard, W. W. (1990). Amphotericin-B – 30 years of
clinical-experience. Rev. Infect. Dis. 12, 308–329. doi: 10.1093/clinids/12.2.308
Garcia-Covarrubias, L., Barratt, D. M., Bartlett, R., Metzinger, S., and Van Meter, K.
(2002). Invasive aspergillosis treated with adjunctive hyperbaric oxygenation: a
retrospective clinical series at a single institution. South. Med. J. 95, 450–456.
doi: 10.1097/00007611-200204000-00015
Ghannoum, M. A., and Rice, L. B. (1999). Antifungal agents: mode of action,
mechanisms of resistance, and correlation of these mechanisms with bacterial
resistance. Clin. Microbiol. Rev. 12, 501–517.
Grahl, N., Puttikamonkul, S., Macdonald, J. M., Gamcsik, M. P., Ngo, L. Y.,
Hohl, T. M., et al. (2011). In vivo hypoxia and a fungal alcohol dehydrogenase
influence the pathogenesis of invasive pulmonary aspergillosis. PLoS Pathog.
7:e1002145. doi: 10.1371/journal.ppat.1002145
Grahl, N., Shepardson, K. M., Chung, D., and Cramer, R. A. (2012). Hypoxia
and fungal pathogenesis: to air or not to air? Eukaryotic Cell 11, 560–570.
doi: 10.1128/EC.00031-12
Gray, K. C., Palacios, D. S., Dailey, I., Endo, M. M., Uno, B. E., Wilcock, B. C., et al.
(2012). Amphotericin primarily kills yeast by simply binding ergosterol. Proc.
Natl. Acad. Sci. U.S.A. 109, 2234–2239. doi: 10.1073/pnas.1117280109
Gsaller, F., Hortschansky, P., Furukawa, T., Carr, P. D., Rash, B., Capilla, J., et al.
(2016). Sterol biosynthesis and azole tolerance is governed by the opposing
actions of SrbA and the CCAAT binding complex. PLoS Pathog. 12:e1005775.
doi: 10.1371/journal.ppat.1005775
Ha, Y., Akiyama, Y., and Xue, Y. (2013). Structure and mechanism of rhomboid
protease. J. Biol. Chem. 288, 15430–15436. doi: 10.1074/jbc.R112.422378
Haas, H. (2012). Iron – a key nexus in the virulence of Aspergillus fumigatus. Front.
Microbiol. 3:28. doi: 10.3389/fmicb.2012.00028
Hampton, R. Y., Gardner, R. G., and Rine, J. (1996). Role of 26S proteasome and
HRD genes in the degradation of 3-hydroxy-3-methylglutaryl-CoA reductase,
Frontiers in Microbiology | www.frontiersin.org 11 February 2017 | Volume 8 | Article 92
fmicb-08-00092 January 30, 2017 Time: 15:15 # 12
Dhingra and Cramer Sterol Biosynthesis Regulation Aspergillus fumigatus
an integral endoplasmic reticulum membrane protein. Mol. Biol. Cell 7, 2029–
2044. doi: 10.1091/mbc.7.12.2029
Han, S., Lone, M. A., Schneiter, R., and Chang, A. (2010). Orm1 and Orm2
are conserved endoplasmic reticulum membrane proteins regulating lipid
homeostasis and protein quality control. Proc. Natl. Acad. Sci. U.S.A. 107,
5851–5856. doi: 10.1073/pnas.0911617107
Hortschansky, P., Ando, E., Tuppatsch, K., Arikawa, H., Kobayashi, T., Kato, M.,
et al. (2015). Deciphering the combinatorial DNA-binding code of the CCAAT-
binding complex and the iron-regulatory basic region leucine zipper (bzip)
transcription factor HapX. J. Biol. Chem. 290, 6058–6070. doi: 10.1074/jbc.
M114.628677
Hu, W. Q., Sillaots, S., Lemieux, S., Davison, J., Kauffman, S., Breton, A., et al.
(2007). Essential gene identification and drug target prioritization in Aspergillus
fumigatus. PLoS Pathog. 3:e24. doi: 10.1371/journal.ppat.0030024
Hua, X. X., Wu, J., Goldstein, J. L., Brown, M. S., and Hobbs, H. H. (1995). Structure
of the human gene encoding sterol regulatory element-binding protein-1
(SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17P11.2
AND 22Q13. Genomics 25, 667–673. doi: 10.1016/0888-7543(95)80009-B
Hughes, A. L., Lee, C. Y., Bien, C. M., and Espenshade, P. J. (2007a). 4-methyl
sterols regulate fission yeast SREBP-Scap under low oxygen and cell stress.
J. Biol. Chem. 282, 24388–24396. doi: 10.1074/jbc.M701326200
Hughes, A. L., Powell, D. W., Bard, M., Eckstein, J., Barbuch, R., Link, A. J., et al.
(2007b). Dap1/PGRMC1 binds and regulates cytochrome P450 enzymes. Cell
Metab. 5, 143–149. doi: 10.1016/j.cmet.2006.12.009
Hughes, A. L., Todd, B. L., and Espenshade, P. J. (2005). SREBP pathway responds
to sterols and functions as an oxygen sensor in fission yeast. Cell 120, 831–842.
doi: 10.1016/j.cell.2005.01.012
Hughes, B. T., and Espenshade, P. J. (2008). Oxygen-regulated degradation of
fission yeast SREBP by Ofd1, a prolyl hydroxylase family member. Embo J. 27,
1491–1501. doi: 10.1038/emboj.2008.83
Hunter, W. N. (2007). The non-mevalonate pathway of isoprenoid precursor
biosynthesis. J. Biol. Chem. 282, 21573–21577. doi: 10.1074/jbc.R700005200
John, B. V., Chamilos, G., and Kontoyiannis, D. P. (2005). Hyperbaric oxygen as
an adjunctive treatment for zygomycosis. Clin. Microbiol. Infect. 11, 515–517.
doi: 10.1111/j.1469-0691.2005.01170.x
Kaplan, C. D., and Kaplan, J. (2009). Iron acquisition and transcriptional
regulation. Chem. Rev. 109, 4536–4552. doi: 10.1021/cr9001676
Kelly, S. L., Lamb, D. C., Kelly, D. E., Manning, N. J., Loeﬄer, J., and Hebart, H.
(1997). Resistance to fluconazole and cross-resistance to amphotericin B in
Candida albicans from AIDS patients caused by defective sterol Delta(5,6)-
desaturation. FEBS Lett. 400, 80–82. doi: 10.1016/S0014-5793(96)01360-9
Kim, J., Haa, H.-J., Kima, S., Choia, A.-R., Leec, S.-J., and Hoec, K.-L. (2015).
Identification of Rbd2 as a candidate protease for sterol regulatory element
binding protein (SREBP) cleavage in fission yeast. Biochem. Biophys. Res.
Commun. 468, 606–610. doi: 10.1016/j.bbrc.2015.10.165
Kobayashi, D., Kondo, K., Uehara, N., Otokozawa, S., Tsuji, N., Yagihashi, A.,
et al. (2002). Endogenous reactive oxygen species is an important mediator
of miconazole antifungal effect. Antimicrob. Agents Chemother. 46, 3113–3117.
doi: 10.1128/AAC.46.10.3113-3117.2002
Kolpen, M., Mousavi, N., Sams, T., Bjarnsholt, T., Ciofu, O., and Moser, C. (2016).
Reinforcement of the bactericidal effect of ciprofloxacin on Pseudomonas
aeruginosa biofilm by hyperbaric oxygen treatment. Int. J. Antimicrob. Agents
47, 163–167. doi: 10.1016/j.ijantimicag.2015.12.005
Koumenis, C., and Wouters, B. G. (2006). “Translating” tumor hypoxia: unfolded
protein response (UPR)-dependent and UPR-independent pathways. Mol.
Cancer Res. 4, 423–436. doi: 10.1158/1541-7786.MCR-06-0150
Krishnan, K., and Askew, D. S. (2014). The fungal UPR A regulatory hub for
virulence traits in the mold pathogen Aspergillus fumigatus. Virulence 5, 334–
340. doi: 10.4161/viru.26571
Krishnan, K., Feng, X., Powers-Fletcher, M. V., Bick, G., Richie, D. L., Woollett,
L. A., et al. (2013). Effects of a defective endoplasmic reticulum-associated
degradation pathway on the stress response, virulence, and antifungal drug
susceptibility of the mold pathogen Aspergillus fumigatus. Eukaryot. Cell 12,
512–519. doi: 10.1128/EC.00319-12
Kurt, T., Vural, A., Temiz, A., Ozbudak, E., Yener, A. U., Sacar, S., et al. (2015).
Adjunctive hyperbaric oxygen therapy or alone antibiotherapy? Methicillin
resistant Staphylococcus aureus mediastinitis in a rat model. Rev. Bras. Cir.
Cardiovasc. 30, 538–543.
Kwon-Chung, K. J., and Sugui, J. A. (2013). Aspergillus fumigatus-What makes
the species a ubiquitous human fungal pathogen? PLoS Pathog. 9:e1003743.
doi: 10.1371/journal.ppat.1003743
Lajoie, P., Moir, R. D., Willis, I. M., and Snapp, E. L. (2012). Kar2p availability
defines distinct forms of endoplasmic reticulum stress in living cells. Mol. Biol.
Cell 23, 955–964. doi: 10.1091/mbc.E11-12-0995
Lambou, K., Lamarre, C., Beau, R., Dufour, N., and Latge, J. P. (2010). Functional
analysis of the superoxide dismutase family in Aspergillus fumigatus. Mol.
Microbiol. 75, 910–923. doi: 10.1111/j.1365-2958.2009.07024.x
Lamoth, F., Juvvadi, P. R., Soderblom, E. J., Moseley, M. A., Asfaw, Y. G.,
and Steinbach, W. J. (2014). Identification of a key lysine residue in heat
shock protein 90 required for azole and echinocandin resistance in Aspergillus
fumigatus. Antimicrob. Agents Chemother. 58, 1889–1896. doi: 10.1128/AAC.
02286-13
Lee, C. Y., Stewart, E. V., Hughes, B. T., and Espenshade, P. J. (2009). Oxygen-
dependent binding of Nro1 to the prolyl hydroxylase Ofd1 regulates SREBP
degradation in yeast. EMBO J. 28, 135–143. doi: 10.1038/emboj.2008.271
Lohi, O., Urban, S., and Freeman, M. (2004). Diverse substrate recognition
mechanisms for rhomboids: thrombomodulin is cleaved by mammalian
rhomboids. Curr. Biol. 14, 236–241. doi: 10.1016/j.cub.2004.01.025
Losada, L., Sugui, J. A., Eckhaus, M. A., Chang, Y. C., Mounaud, S., Figat, A., et al.
(2015). Genetic analysis using an isogenic mating pair of Aspergillus fumigatus
identifies azole resistance genes and lack of MAT locus’s role in virulence. PLoS
Pathog. 11:e1004834. doi: 10.1371/journal.ppat.1004834
Lu, X., Li, Y., Liu, J., Cao, X., Wang, X., Wang, D., et al. (2008). 3 beta-
hydroxysteroid-Delta 24 reductase is a hydrogen peroxide scavenger, protecting
cells from oxidative stress-induced apoptosis. Endocrinology 149, 3267–3273.
doi: 10.1210/en.2008-0024
Martel, C. M., Parker, J. E., Bader, O., Weig, M., Gross, U., and Warrilow, A. G.
(2010). Identification and characterization of four azole-resistant erg3 mutants
of Candida albicans. Antimicrob. Agents Chemother. 54, 4527–4533. doi: 10.
1128/AAC.00348-10
Mast, N., Charvet, C., Pikuleva, I. A., and Stout, C. D. (2010). Structural
basis of drug binding to CYP46A1, an enzyme that controls cholesterol
turnover in the brain. J. Biol. Chem. 285, 31783–31795. doi: 10.1074/jbc.M110.
143313
Mayr, A., and Lass-Flörl, C. (2011). Epidemiology and antifungal resistance in
invasive aspergillosis according to primary disease – review of the literature.
Eur. J. Med. Res. 16, 153–157. doi: 10.1186/2047-783X-16-4-153
Meletiadis, J., Antachopoulos, C., Stergiopoulou, T., Pournaras, S., Roilides, S.,
and Walsh, T. J. (2007). Differential fungicidal activities of amphotericin
B and voriconazole against Aspergillus species determined by microbroth
methodology. Antimicrob. Agents Chemother. 51, 3329–3337. doi: 10.1128/
AAC.00345-07
Mellado, E., Diaz-Guerra, T. M., Cuenca-Estrella, M., and Rodriguez-Tudela, J. L.
(2001). Identification of two different 14-alpha sterol demethylase-related genes
(cyp51A and cyp51B) in Aspergillus fumigatus and other Aspergillus species.
J. Clin. Microbiol. 39, 2431–2438. doi: 10.1128/JCM.39.7.2431-2438.2001
Mellado, E., Garcia-Effron, G., Buitrago, M. J., Alcazar-Fuoli, L., Cuenca-
Estrella, M., and Rodriguez-Tudela, J. L. (2005). Targeted gene disruption of
the 14-alpha sterol demethylase (cyp51A) in Aspergillus fumigatus and its role
in azole drug susceptibility. Antimicrob. Agents Chemother. 49, 2536–2538.
doi: 10.1128/AAC.49.6.2536-2538.2005
Miliutina, N., Ananian, A. A., Sapozhnikov, V. M., Novikova, E. I., Kostkin,
V. B., and Dashevskii, B. S. (1992). Effects of prolonged hyperbarism on lipid
peroxidation and structural-functional state of erythrocytes. Biull. Eksp Biol.
Med. 113, 474–476.
Moen, I., and Stuhr, L. E. B. (2012). Hyperbaric oxygen therapy and cancer-a
review. Target. Oncol. 7, 233–242. doi: 10.1007/s11523-012-0233-x
Moore, K. A., and Hollien, J. (2012). The unfolded protein response in secretory cell
function. Annu. Rev. Genet. 46, 165–183. doi: 10.1146/annurev-genet-110711-
155644
Nebert, D. W., and Russell, D. W. (2002). Clinical importance of the cytochromes
P450. Lancet 360, 1155–1162. doi: 10.1016/S0140-6736(02)11203-7
Nes, W. D., Janssen, G. G., Crumley, F. G., Kalinowska, M., and Akihisa, T.
(1993). The structural requirements of sterols for membrane-function in
Saccharomyces cerevisiae. Arch. Biochem. Biophys. 300, 724–733. doi: 10.1006/
abbi.1993.1100
Frontiers in Microbiology | www.frontiersin.org 12 February 2017 | Volume 8 | Article 92
fmicb-08-00092 January 30, 2017 Time: 15:15 # 13
Dhingra and Cramer Sterol Biosynthesis Regulation Aspergillus fumigatus
Nes, W. D., Xu, S. H., and Haddon, W. F. (1989). Evidence for similarities and
differences in the biosynthesis of fungal sterols. Steroids 53, 533–558. doi: 10.
1016/0039-128X(89)90030-5
Nes, W. D., Zhou, W., Dennis, A. D., Li, H., Jia, Z., Keith, R. A., et al.
(2002). Purification, characterization and catalytic properties of human sterol
8-isomerase. Biochem. J. 367, 587–599. doi: 10.1042/bj20020551
Odds, F. C., Brown, A. J., and Gow, N. A. (2003). Antifungal agents: mechanisms
of action. Trends Microbiol. 11, 272–279. doi: 10.1016/S0966-842X(03)00117-3
Odom, A. R. (2011). Five questions about non-mevalonate isoprenoid biosynthesis.
PLoS Pathog. 7:e1002323. doi: 10.1371/journal.ppat.1002323
Pandey, A. V., and Flück, C. E. (2013). NADPH P450 oxidoreductase: structure,
function, and pathology of diseases. Pharmacol. Ther. 138, 229–254. doi: 10.
1016/j.pharmthera.2013.01.010
Parker, J. E., Warrilow, A. G., Price, C. L., Mullins, J. G., Kelly, D. E., and Kelly, S. L.
(2014). Resistance to antifungals that target CYP51. J. Chem. Biol. 7, 143–161.
doi: 10.1007/s12154-014-0121-1
Parks, L. W., and Casey, W. M. (1995). Physiological implications of sterol
biosynthesis in yeast. Annu. Rev. Microbiol. 49, 95–116. doi: 10.1146/annurev.
micro.49.1.95
Patterson, T. F., Thompson, G. R. III, Denning, D. W., Fishman, J. A.,
Hadley, S., Herbrecht, R., et al. (2016). Practice guidelines for the diagnosis and
management of aspergillosis: 2016 update by the infectious diseases society of
america. Clin. Infect. Dis. 63, e1–e60. doi: 10.1093/cid/ciw326
Peng, Y. B., Dong, D., Jiang, C., Yu, B., Wang, X., and Ji, Y. (2012). Relationship
between respiration deficiency and azole resistance in clinical Candida glabrata.
FEMS Yeast Res. 12, 719–727. doi: 10.1111/j.1567-1364.2012.00821.x
Pineau, L., Colas, J., Dupont, S., Beney, L., Fleurat-Lessard, P., Berjeaud, J. M., et al.
(2009). Lipid-induced ER stress: synergistic effects of sterols and saturated fatty
acids. Traffic 10, 673–690. doi: 10.1111/j.1600-0854.2009.00903.x
Podust, L. M., Poulos, T. L., and Waterman, M. R. (2001). Crystal structure of
cytochrome P450 14 alpha-sterol demethylase (CYP51) from Mycobacterium
tuberculosis in complex with azole inhibitors. Proc. Natl. Acad. Sci. U.S.A. 98,
3068–3073. doi: 10.1073/pnas.061562898
Porter, J. R., Burg, J. S., Espenshade, P. J., and Iglesias, P. A. (2010). Ergosterol
regulates sterol regulatory element binding protein (SREBP) cleavage in fission
yeast. J. Biol. Chem. 285, 41051–41061. doi: 10.1074/jbc.M110.144337
Punga, T., Bengoechea-Alonso, M. T., and Ericsson, J. (2006). Phosphorylation
and ubiquitination of the transcription factor sterol regulatory element-binding
protein-1 in response to DNA binding. J. Biol. Chem. 281, 25278–25286. doi:
10.1074/jbc.M604983200
Qiao, J., Kontoyiannis, D. P., Wan, Z., Li, R., and Liu, W. (2007). Antifungal
activity of statins against Aspergillus species. Med. Mycol. 45, 589–593. doi:
10.1080/13693780701397673
Rawson, R. B., DeBose-Boyd, R., Goldstein, J. L., and Brown, M. S. (1999). Failure to
cleave sterol regulatory element-binding proteins (SREBPs) causes cholesterol
auxotrophy in Chinese hamster ovary cells with genetic absence of SREBP
cleavage-activating protein. J. Biol. Chem. 274, 28549–28556. doi: 10.1074/jbc.
274.40.28549
Rawson, R. B., Zelenski, N. G., Nijhawan, D., Ye, J., Sakai, J., Hasan, M. T.,
et al. (1997). Complementation cloning of S2P, a gene encoding a putative
metalloprotease required for intramembrane cleavage of SREBPs. Mol. Cell. 1,
47–57. doi: 10.1016/S1097-2765(00)80006-4
Richie, D. L., Hartl, L., Aimanianda, V., Winters, M. S., Fuller, K. K., Miley, M. D.,
et al. (2009). A role for the Unfolded Protein Response (UPR) in virulence
and antifungal susceptibility in Aspergillus fumigatus. PLoS Pathog. 5:e1000258.
doi: 10.1371/journal.ppat.1000258
Romero-Ramirez, L., Cao, H., Nelson, D., Hammond, E., Lee, A. H., Yoshida, H.,
et al. (2004). XBP1 is essential for survival under hypoxic conditions and is
required for tumor growth. Cancer Res. 64, 5943–5947. doi: 10.1158/0008-5472.
CAN-04-1606
Rosenfeld, E., and Beauvoit, B. (2003). Role of the non-respiratory pathways
in the utilization of molecular oxygen by Saccharomyces cerevisiae. Yeast 20,
1115–1144. doi: 10.1002/yea.1026
Sanati, H., Belanger, P., Fratti, R., and Ghannoum, M. (1997). A new triazole,
voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and
Candida krusei. Antimicrob. Agents Chemother. 41, 2492–2496.
Schenkman, J. B., and Jansson, I. (2003). The many roles of cytochrome b5.
Pharmacol. Ther. 97, 139–152. doi: 10.1016/S0163-7258(02)00327-3
Schrettl, M., Bignell, E., Kragl, C., Joechl, C., Rogers, T., Arst, H. N. Jr., et al. (2004).
Siderophore biosynthesis but not reductive iron assimilation is essential for
Aspergillus fumigatus virulence. J. Exp. Med. 200, 1213–1219. doi: 10.1084/jem.
20041242
Schrettl, M., Bignell, E., Kragl, C., Sabiha, Y., Loss, O., Eisendle, M., et al. (2007).
Distinct roles for intra- and extracellular siderophores during Aspergillus
fumigatus infection. PLoS Pathog. 3:1195–1207. doi: 10.1371/journal.ppat.
0030128
Schrettl, M., Kim, H. S., Eisendle, M., Kragl, C., Nierman, W. C., Heinekamp, T.,
et al. (2008). SreA-mediated iron regulation in Aspergillus fumigatus. Mol.
Microbiol. 70, 27–43. doi: 10.1111/j.1365-2958.2008.06376.x
Segal, E., Menhusen, M. J., and Shawn, S. (2007). Hyperbaric oxygen in the
treatment of invasive fungal infections: a single-center experience. Israel Med.
Assoc. J. 9, 355–357.
Shapiro, R. S., Robbins, N., and Cowen, L. E. (2011). Regulatory circuitry governing
fungal development, drug resistance, and disease. Microbiol. Mol. Biol. Rev. 75,
213–267. doi: 10.1128/MMBR.00045-10
Snelders, E., Huis In ’t Veld, R. A., Rijs, A. J., Kema, G. H., Melchers, W. J., and
Verweij, P. E. (2009). Possible environmental origin of resistance of Aspergillus
fumigatus to medical triazoles. Appl. Environ. Microbiol. 75, 4053–4057. doi:
10.1128/AEM.00231-09
Snelders, E., Karawajczyk, A., Verhoeven, R., Venselaar, H., Schaftenaar, G.,
Verweij, P. E., et al. (2011). The structure-function relationship of the
Aspergillus fumigatus cyp51A L98H conversion by site-directed mutagenesis:
the mechanism of L98H azole resistance. Fungal Genet. Biol. 48, 1062–1070.
doi: 10.1016/j.fgb.2011.08.002
Song, J. X., Zhai, P., Zhang, Y., Zhang, C., Sang, H., Han, G., et al. (2016). The
Aspergillus fumigatus damage resistance protein family coordinately regulates
ergosterol biosynthesis and azole susceptibility. mBio 7, e01919-15. doi: 10.
1128/mBio.01919-15
Stewart, E. V., Lloyd, S. J., Burg, J. S., Nwosu, C. C., Lintner, R. E., Daza, R.,
et al. (2012). Yeast sterol regulatory element-binding protein (SREBP) cleavage
requires Cdc48 and Dsc5, a ubiquitin regulatory X domain-containing subunit
of the golgi DSC E3 ligase. J. Biol. Chem. 287, 672–681. doi: 10.1074/jbc.M111.
317370
Stewart, E. V., Nwosu, C. C., Tong, Z., Roguev, A., Cummins, T. D., Kim, D. U.,
et al. (2011). Yeast SREBP cleavage activation requires the golgi Dsc E3 ligase
complex. Mol. Cell 42, 160–171. doi: 10.1016/j.molcel.2011.02.035
Stolz, A., Hilt, W., Buchberger, A., and Wolf, D. H. (2011). Cdc48: a power machine
in protein degradation. Trends Biochem. Sci. 36, 515–523. doi: 10.1016/j.tibs.
2011.06.001
Sun, L. F., Li, X. C., and Shi, Y. (2016). Structural biology of intramembrane
proteases: mechanistic insights from rhomboid and S2P to gamma-secretase.
Curr. Opin. Struct. Biol. 37, 97–107. doi: 10.1016/j.sbi.2015.12.008
Sun, L. P., Li, L., Goldstein, J. L., and Brown, M. S. (2005). Insig required for sterol-
mediated inhibition of Scap/SREBP binding to COPII proteins in vitro. J. Biol.
Chem. 280, 26483–26490. doi: 10.1074/jbc.M504041200
Sundqvist, A., Bengoechea-Alonso, M. T., Ye, X., Lukiyanchuk, V., Jin, J., Wade
Harper, J., et al. (2005). Control of lipid metabolism by phosphorylation-
dependent degradation of the SREBP family of transcription factors by
SCFFbw7. Cell Metab. 1, 379–391. doi: 10.1016/j.cmet.2005.04.010
Thom, S. R. (2011). Hyperbaric oxygen: its mechanisms and efficacy. Plast.
Reconstr. Surg. 127, 131S–141S. doi: 10.1097/PRS.0b013e3181fbe2bf
Tobert, J. A. (2003). Lovastatin and beyond: the history of the HMG-CoA reductase
inhibitors. Nat. Rev. Drug Discov. 2, 517–526. doi: 10.1038/nrd1112
Todd, B. L., Stewart, E. V., Burg, J. S., Hughes, A. L., and Espenshade, P. J. (2006).
Sterol regulatory element binding protein is a principal regulator of anaerobic
gene expression in fission yeast. Mol. Cell. Biol. 26, 2817–2831. doi: 10.1128/
MCB.26.7.2817-2831.2006
Travers, K. J., Patil, C. K., Wodicka, L., Lockhart, D. J., Weissman, J. S.,
and Walter, P. (2000). Functional and genomic analyses reveal an essential
coordination between the unfolded protein response and ER-associated
degradation. Cell 101, 249–258. doi: 10.1016/S0092-8674(00)80835-1
Tsai, Y. C., and Weissman, A. M. (2010). The unfolded protein response,
degradation from the endoplasmic reticulum, and cancer. Genes Cancer 1,
764–778. doi: 10.1177/1947601910383011
Vaknin, Y., Hillmann, F., Iannitti, R., Ben Baruch, N., Sandovsky-Losica, H.,
Shadkchan, Y., et al. (2016). Identification and characterization of a novel
Frontiers in Microbiology | www.frontiersin.org 13 February 2017 | Volume 8 | Article 92
fmicb-08-00092 January 30, 2017 Time: 15:15 # 14
Dhingra and Cramer Sterol Biosynthesis Regulation Aspergillus fumigatus
Aspergillus fumigatus rhomboid family putative protease, RbdA, involved in
hypoxia sensing and virulence. Infect. Immun. 84, 1866–1878. doi: 10.1128/IAI.
00011-16
Verweij, P. E., Chowdhary, A., Melchers, W. J., and Meis, J. F. (2016). Azole
resistance in Aspergillus fumigatus: can we retain the clinical use of mold-active
antifungal azoles? Clin. Infect. Dis. 62, 362–368. doi: 10.1093/cid/civ885
Volmer, R., and Ron, D. (2015). Lipid-dependent regulation of the unfolded
protein response. Curr. Opin. Cell Biol. 33, 67–73. doi: 10.1016/j.ceb.2014.12.
002
Wang, M., and Kaufman, R. J. (2014). The impact of the endoplasmic reticulum
protein-folding environment on cancer development. Nat. Rev. Cancer 14,
581–597. doi: 10.1038/nrc3800
Warrilow, A. G., Parker, J. E., Kelly, D. E., and Kelly, S. L. (2013). Azole affinity
of sterol 14 alpha-demethylase (CYP51) enzymes from Candida albicans and
Homo sapiens. Antimicrob. Agents Chemother. 57, 1352–1360. doi: 10.1128/
AAC.02067-12
Warrilow, A. G. S., Melo, N., Martel, C. M., Parker, J. E., Nes, W. D.,
Kelly, S. L., et al. (2010). Expression, purification, and characterization of
Aspergillus fumigatus sterol 14-alpha demethylase (CYP51) Isoenzymes A and
B. Antimicrob. Agents Chemother. 54, 4225–4234. doi: 10.1128/AAC.00316-10
Wiederhold, N. P., Gil, V. G., Gutierrez, F., Lindner, J. R., Albataineh, M. T.,
McCarthy, D. I., et al. (2016). First detection of TR34 L98H and TR46 Y121F
T289A Cyp51 mutations in Aspergillus fumigatus isolates in the United States.
J. Clin. Microbiol. 54, 168–171. doi: 10.1128/JCM.02478-15
Willger, S. D., Cornish, E. J., Chung, D., Fleming, B. A., Lehmann, M. M., and
Puttikamonkul, S. (2012). Dsc orthologs are required for hypoxia adaptation,
triazole drug responses, and fungal virulence in Aspergillus fumigatus. Eukaryot.
Cell 11, 1557–1567. doi: 10.1128/EC.00252-12
Willger, S. D., Puttikamonkul, S., Kim, K. H., Burritt, J. B., Grahl, N., Metzler,
L. J., et al. (2008). A sterol-regulatory element binding protein is required
for cell polarity, hypoxia adaptation, azole drug resistance, and virulence
in Aspergillus fumigatus. PLoS Pathog. 4:e1000200. doi: 10.1371/journal.ppat.
1000200
Xiong, Q. B., Hassan, S. A., Wilson, W. K., Han, X. Y., May, G. S., Tarrand, J. J.,
et al. (2005). Cholesterol import by Aspergillus fumigatus and its influence
on antifungal potency of sterol biosynthesis inhibitors. Antimicrob. Agents
Chemother. 49, 518–524. doi: 10.1128/AAC.49.2.518-524.2005
Yang, T., Espenshade, P. J., Wright, M. E., Yabe, D., Gong, Y., Aebersold, R.,
et al. (2002). Crucial step in cholesterol homeostasis: sterols promote binding
of SCAP to INSIG-1, a membrane protein that facilitates retention of SREBPs
in ER. Cell 110, 489–500. doi: 10.1016/S0092-8674(02)00872-3
Yasmin, S., Alcazar-Fuoli, L., Gründlinger, M., Puempel, T., Cairns, T.,
Blatzer, M., et al. (2012). Mevalonate governs interdependency of ergosterol and
siderophore biosyntheses in the fungal pathogen Aspergillus fumigatus. Proc.
Natl. Acad. Sci. U.S.A. 109, E497–E504. doi: 10.1073/pnas.1106399108
Yokoyama, C., Wang, X., Briggs, M. R., Admon, A., Wu, J., Hua, X., et al.
(1993). SREBP-1, a basic-helix-loop-helix-leucine zipper protein that controls
transcription of the low-density-lipoprotein receptor gene. Cell 75, 187–197.
doi: 10.1016/S0092-8674(05)80095-9
Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Copyright © 2017 Dhingra and Cramer. This is an open-access article distributed
under the terms of the Creative Commons Attribution License (CC BY). The use,
distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal
is cited, in accordance with accepted academic practice. No use, distribution or
reproduction is permitted which does not comply with these terms.
Frontiers in Microbiology | www.frontiersin.org 14 February 2017 | Volume 8 | Article 92
